Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, announced the pricing of its initial […]
Pivot Bio announced it is named to Fast Company’s annual list of the World’s Most Innovative Companies in 2019. The company was recognized for its transformational work in agriculture, earning Pivot Bio the eighth spot […]
Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative and neuropsychiatric diseases, today announced the completion of a $25 million series B equity financing. New investor Seventure Partners, […]
Acurx Pharmaceuticals, LLC (“Acurx” or the “Company”), a privately-held, clinical stage, biopharmaceutical company developing new antibiotics for difficult-to-treat bacterial infections, announced today that its lead product candidate, ACX-362E, has successfully completed the 32-subject, double-blinded, placebo-controlled, […]
KNOW Bio, LLC., (the Company), a North Carolina developer of nitric oxide-based medical technology and related biotechnology companies, announced that the Company has formed a new wholly-owned operating subsidiary, Digestive Health Therapeutics, Inc, to develop […]
DuPont Nutrition & Health and Lonza Specialty Ingredients announce an agreement under which the leading biotechnology and specialty ingredient company Lonza will manufacture and supply CARE4U™ 2’-FL – a human milk oligosaccharide (HMOs). This strategic […]
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced the establishment of a new subsidiary – LaVie Bio Ltd (LaVie). The new company will focus on […]
Bacteria in the gut do far more than help digest food in the stomachs of their hosts, they can also tell the genes in their mammalian hosts what to do. A study published today in […]
BiomX Ltd., a microbiome company developing customized phage therapies, announced the closing of a $32 million series B equity financing. The financing was led by existing investors OrbiMed, Johnson & Johnson Innovation – JJDC, Inc., […]
S-Biomedic, a pioneer in patented human microbiome skin applications, announces the successful completion of their second Series A financing round. The second closing welcomed a new investor, DSM Venturing and was also supported by existing […]
“The association of microbial GABA metabolism [the brain protein gamma-aminobutyric acid (GABA)] with mental health is highly compelling.” Jack Gilbert, Argonne microbial ecologist Researchers have established a correlation between depression and a group of neurotransmitter-producing […]